Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

631 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression.
Guo W, Machado-Vieira R, Mathew S, Murrough JW, Charney DS, Grunebaum M, Oquendo MA, Kadriu B, Akula N, Henter I, Yuan P, Merikangas K, Drevets W, Furey M, Mann JJ, McMahon FJ, Zarate CA Jr, Shugart YY. Guo W, et al. Among authors: charney ds. Transl Psychiatry. 2018 Dec 14;8(1):280. doi: 10.1038/s41398-018-0311-7. Transl Psychiatry. 2018. PMID: 30552317 Free PMC article.
Antidepressant effects of ketamine in depressed patients.
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH. Berman RM, et al. Among authors: charney ds. Biol Psychiatry. 2000 Feb 15;47(4):351-4. doi: 10.1016/s0006-3223(99)00230-9. Biol Psychiatry. 2000. PMID: 10686270 Clinical Trial.
The cellular neurobiology of depression.
Manji HK, Drevets WC, Charney DS. Manji HK, et al. Among authors: charney ds. Nat Med. 2001 May;7(5):541-7. doi: 10.1038/87865. Nat Med. 2001. PMID: 11329053 Review.
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
Charney DS, Nemeroff CB, Lewis L, Laden SK, Gorman JM, Laska EM, Borenstein M, Bowden CL, Caplan A, Emslie GJ, Evans DL, Geller B, Grabowski LE, Herson J, Kalin NH, Keck PE Jr, Kirsch I, Krishnan KR, Kupfer DJ, Makuch RW, Miller FG, Pardes H, Post R, Reynolds MM, Roberts L, Rosenbaum JF, Rosenstein DL, Rubinow DR, Rush AJ, Ryan ND, Sachs GS, Schatzberg AF, Solomon S; Consensus Development Panel. Charney DS, et al. Arch Gen Psychiatry. 2002 Mar;59(3):262-70. doi: 10.1001/archpsyc.59.3.262. Arch Gen Psychiatry. 2002. PMID: 11879164 Review.
Reduced serotonin type 1A receptor binding in panic disorder.
Neumeister A, Bain E, Nugent AC, Carson RE, Bonne O, Luckenbaugh DA, Eckelman W, Herscovitch P, Charney DS, Drevets WC. Neumeister A, et al. Among authors: charney ds. J Neurosci. 2004 Jan 21;24(3):589-91. doi: 10.1523/JNEUROSCI.4921-03.2004. J Neurosci. 2004. PMID: 14736842 Free PMC article. Clinical Trial.
Discovering endophenotypes for major depression.
Hasler G, Drevets WC, Manji HK, Charney DS. Hasler G, et al. Among authors: charney ds. Neuropsychopharmacology. 2004 Oct;29(10):1765-81. doi: 10.1038/sj.npp.1300506. Neuropsychopharmacology. 2004. PMID: 15213704 Review.
631 results